TheraCryf PLC TCF

LSE · United Kingdom · Health Services

GBp 0.18000.00 (0.00%)

Market closed· Oct 1, 2026, 10:22 AM UTC· GBp · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

TheraCryf PLC TCF

LSE · United Kingdom · Health Services

GBp 0.18000.00 (0.00%)

Market closed· Oct 1, 2026, 10:22 AM UTC· GBp · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-7.69% · 6MFull-screen chart

Open GBp 0.00High GBp 0.1800Low GBp 0.1800Close GBp 0.1800Volume 2.56M

Oct 1, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: GBp 0.1800
Volume: 2.56M
Market cap: £4.92M
Next earnings date: 2026-12-17
Avg. volume (1Y): 3.63M

Performance

1 week

+2.86%

1 month

-5.26%

3 months

-16.28%

6 months

-7.69%

Year to date

-10.00%

1 year

-16.28%

Total return, dividends included.

Company profile

Sector: Health Services
Industry: Medical/Nursing Services
Country: United Kingdom
Exchange: LSE
Shares outstanding: 2.73B
Employees: 9
ISIN: GB00BSVYN304
Beta: 2.31

Technical view

Below averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceDec 12, 2025

TheraCryf PLC (LSE:TCF) Half Year 2026 Earnings Call Highlights: Strategic Advances and ...

TheraCryf PLC (LSE:TCF) showcases robust financial health and strategic progress, with a focus on its promising orexin-1 program and global patent expansion.

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.